Genetec Technology Berhad

KLSE:GENETEC Rapporto sulle azioni

Cap. di mercato: RM 775.1m

La traduzione di questa pagina è sperimentale e in fase di sviluppo. Siamo lieti di ricevere vostro !

Genetec Technology Berhad Salute del bilancio

Salute finanziaria criteri di controllo 6/6

Genetec Technology Berhad ha un patrimonio netto totale di MYR485.3M e un debito totale di MYR22.4M, che porta il suo rapporto debito/patrimonio netto a 4.6%. Le sue attività totali e le sue passività totali sono rispettivamente MYR591.3M e MYR106.0M. L'EBIT di Genetec Technology Berhad è MYR86.1M rendendo il suo rapporto di copertura degli interessi 36. Ha liquidità e investimenti a breve termine pari a MYR180.3M.

Informazioni chiave

3.0%

Rapporto debito/patrimonio netto

RM 14.80m

Debito

Indice di copertura degli interessi419.2x
ContantiRM 164.16m
Patrimonio nettoRM 496.73m
Totale passivitàRM 70.98m
Totale attivitàRM 567.71m

Aggiornamenti recenti sulla salute finanziaria

Recent updates

Genetec Technology Berhad (KLSE:GENETEC) Analysts Are More Bearish Than They Used To Be

Aug 27
Genetec Technology Berhad (KLSE:GENETEC) Analysts Are More Bearish Than They Used To Be

Not Many Are Piling Into Genetec Technology Berhad (KLSE:GENETEC) Stock Yet As It Plummets 27%

Aug 19
Not Many Are Piling Into Genetec Technology Berhad (KLSE:GENETEC) Stock Yet As It Plummets 27%

Is Genetec Technology Berhad (KLSE:GENETEC) A Risky Investment?

Aug 06
Is Genetec Technology Berhad (KLSE:GENETEC) A Risky Investment?

Genetec Technology Berhad's (KLSE:GENETEC) P/E Still Appears To Be Reasonable

Feb 26
Genetec Technology Berhad's (KLSE:GENETEC) P/E Still Appears To Be Reasonable

Slowing Rates Of Return At Genetec Technology Berhad (KLSE:GENETEC) Leave Little Room For Excitement

Jan 15
Slowing Rates Of Return At Genetec Technology Berhad (KLSE:GENETEC) Leave Little Room For Excitement

Genetec Technology Berhad's (KLSE:GENETEC) CEO Will Probably Have Their Compensation Approved By Shareholders

Sep 22
Genetec Technology Berhad's (KLSE:GENETEC) CEO Will Probably Have Their Compensation Approved By Shareholders

Does Genetec Technology Berhad (KLSE:GENETEC) Deserve A Spot On Your Watchlist?

Feb 08
Does Genetec Technology Berhad (KLSE:GENETEC) Deserve A Spot On Your Watchlist?

Genetec Technology Berhad (KLSE:GENETEC) Is Investing Its Capital With Increasing Efficiency

Dec 28
Genetec Technology Berhad (KLSE:GENETEC) Is Investing Its Capital With Increasing Efficiency

Does Genetec Technology Berhad (KLSE:GENETEC) Have A Healthy Balance Sheet?

Nov 17
Does Genetec Technology Berhad (KLSE:GENETEC) Have A Healthy Balance Sheet?

Investors Shouldn't Overlook Genetec Technology Berhad's (KLSE:GENETEC) Impressive Returns On Capital

Aug 16
Investors Shouldn't Overlook Genetec Technology Berhad's (KLSE:GENETEC) Impressive Returns On Capital

Genetec Technology Berhad (KLSE:GENETEC) Has A Pretty Healthy Balance Sheet

Jul 21
Genetec Technology Berhad (KLSE:GENETEC) Has A Pretty Healthy Balance Sheet

Genetec Technology Berhad (KLSE:GENETEC) Yearly Results Just Came Out: Here's What Analysts Are Forecasting For This Year

May 30
Genetec Technology Berhad (KLSE:GENETEC) Yearly Results Just Came Out: Here's What Analysts Are Forecasting For This Year

Genetec Technology Berhad's (KLSE:GENETEC) Intrinsic Value Is Potentially 93% Above Its Share Price

Apr 28
Genetec Technology Berhad's (KLSE:GENETEC) Intrinsic Value Is Potentially 93% Above Its Share Price

Why We Like The Returns At Genetec Technology Berhad (KLSE:GENETEC)

Mar 23
Why We Like The Returns At Genetec Technology Berhad (KLSE:GENETEC)

Genetec Technology Berhad (KLSE:GENETEC) Seems To Use Debt Quite Sensibly

Feb 24
Genetec Technology Berhad (KLSE:GENETEC) Seems To Use Debt Quite Sensibly

Genetec Technology Berhad (KLSE:GENETEC) Seems To Use Debt Quite Sensibly

Nov 04
Genetec Technology Berhad (KLSE:GENETEC) Seems To Use Debt Quite Sensibly

The CEO Of Genetec Technology Berhad (KLSE:GENETEC) Might See A Pay Rise On The Horizon

Sep 08
The CEO Of Genetec Technology Berhad (KLSE:GENETEC) Might See A Pay Rise On The Horizon

Genetec Technology Berhad's (KLSE:GENETEC) Robust Earnings Are Not All Good News For Shareholders

Aug 05
Genetec Technology Berhad's (KLSE:GENETEC) Robust Earnings Are Not All Good News For Shareholders

Genetec Technology Berhad's (KLSE:GENETEC) Returns On Capital Are Heading Higher

Jul 30
Genetec Technology Berhad's (KLSE:GENETEC) Returns On Capital Are Heading Higher

Is Genetec Technology Berhad (KLSE:GENETEC) Using Debt In A Risky Way?

Jun 11
Is Genetec Technology Berhad (KLSE:GENETEC) Using Debt In A Risky Way?

How Well Is Genetec Technology Berhad (KLSE:GENETEC) Allocating Its Capital?

Feb 10
How Well Is Genetec Technology Berhad (KLSE:GENETEC) Allocating Its Capital?

Why Genetec Technology Berhad's (KLSE:GENETEC) CEO Pay Matters

Jan 14
Why Genetec Technology Berhad's (KLSE:GENETEC) CEO Pay Matters

Here's Why Genetec Technology Berhad (KLSE:GENETEC) Can Manage Its Debt Responsibly

Dec 24
Here's Why Genetec Technology Berhad (KLSE:GENETEC) Can Manage Its Debt Responsibly

Genetec Technology Berhad's (KLSE:GENETEC) Has Performed Well But Fundamentals Look Varied: Is There A Clear Direction For The Stock?

Dec 03
Genetec Technology Berhad's (KLSE:GENETEC) Has Performed Well But Fundamentals Look Varied: Is There A Clear Direction For The Stock?

Analisi della posizione finanziaria

Passività a breve termine: Le attività a breve termine ( MYR449.2M ) di GENETEC superano le sue passività a breve termine ( MYR95.6M ).

Passività a lungo termine: Le attività a breve termine di GENETEC ( MYR449.2M ) superano le sue passività a lungo termine ( MYR10.3M ).


Storia e analisi del rapporto debito/patrimonio netto

Livello di debito: GENETEC ha più liquidità del suo debito totale.

Riduzione del debito: Il rapporto debito/patrimonio netto di GENETEC si è ridotto da 18.9% a 4.6% negli ultimi 5 anni.

Copertura del debito: Il debito di GENETEC è ben coperto dal flusso di cassa operativo ( 213.5% ).

Copertura degli interessi: I pagamenti degli interessi sul debito di GENETEC sono ben coperti dall'EBIT ( 36 x copertura).


Bilancio


Scoprire le aziende sane